Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNexus Gene Lab (BGLC) Current Taxes (2018 - 2023)

BioNexus Gene Lab's Current Taxes history spans 6 years, with the latest figure at $2177.0 for Q3 2023.

  • Quarterly results put Current Taxes at $2177.0 for Q3 2023, changed N/A from a year ago — trailing twelve months through Sep 2023 was $2177.0 (changed N/A YoY), and the annual figure for FY2021 was $97585.0, up 59.16%.
  • Current Taxes for Q3 2023 was $2177.0 at BioNexus Gene Lab, down from $40104.0 in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $148199.0 in Q3 2021 to a low of $174.0 in Q2 2020.
  • The 5-year median for Current Taxes is $34338.0 (2019), against an average of $48987.1.
  • The sharpest move saw Current Taxes crashed 99.49% in 2020, then soared 60912.07% in 2021.
  • Year by year, Current Taxes stood at $33983.0 in 2019, then skyrocketed by 80.42% to $61313.0 in 2020, then skyrocketed by 59.16% to $97585.0 in 2021, then crashed by 58.9% to $40104.0 in 2022, then plummeted by 94.57% to $2177.0 in 2023.
  • According to Business Quant data, Current Taxes over the past three periods came in at $2177.0, $40104.0, and $71705.0 for Q3 2023, Q2 2022, and Q1 2022 respectively.